Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The ReS3-T program is the result of a collaboration with KU Leuven’s Centre for Drug Design and Discovery (CD3). ReS3-T acts via a novel proprietary target, Pde6δ, to control neuronal activity.
Lead Product(s): ReS3-T
Therapeutic Area: Neurology Product Name: ReS3-T
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: National Institute of Neurological Disorders
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration November 04, 2021
Details:
RES19-T has shown to produce an acute response, restoring calcium homeostasis and synaptic plasticity, aim to address the disease at its root and restore cognition in patients by reducing the cellular damage associated with memory loss.
Lead Product(s): RES19-T
Therapeutic Area: Neurology Product Name: RES19-T
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 21, 2021
Details:
Proceeds from the fundraise will allow completion of proof-of-concept clinical trials for both the Alzheimer’s and the diabetes programs. A first-in-human trial of RES19-T for Alzheimer’s was initiated in 2020.
Lead Product(s): RES19-T
Therapeutic Area: Neurology Product Name: RES19-T
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Korys Investments
Deal Size: $29.0 million Upfront Cash: Undisclosed
Deal Type: Series B Financing January 21, 2021
Details:
RES19-T, a first-in-class small molecule, represents a novel approach to treat Alzheimer’s Disease (AD), aiming to address the disease at its root and restore cognition in patients by reducing the cellular damage associated with memory loss.
Lead Product(s): RES19-T
Therapeutic Area: Neurology Product Name: RES19-T
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 03, 2020